Global and Japan Circulating Biomarker for Liquid Biopsy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2026
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2015-2026)
2.2 Global Circulating Biomarker for Liquid Biopsy Growth Trends by Regions
2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Market Size
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2015-2020)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2015-2020)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2019
3.5 Key Players Circulating Biomarker for Liquid Biopsy Area Served
3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type (2015-2026)
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2015-2020)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2021-2026)
5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application (2015-2026)
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2015-2020)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2015-2026)
6.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2015-2026)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Circulating Biomarker for Liquid Biopsy Market Size (2015-2026)
8.2 China Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
8.3 China Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
8.4 China Circulating Biomarker for Liquid Biopsy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Circulating Biomarker for Liquid Biopsy Market Size (2015-2026)
9.2 Japan Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
9.3 Japan Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
9.4 Japan Circulating Biomarker for Liquid Biopsy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size (2015-2026)
10.2 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
10.3 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
10.4 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020))
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.3.5 GE Healthcare Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Details
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.4.5 Epigenomics AG Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.5.5 Agilent Technologies Recent Development
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.6.5 Biocept Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.7.5 Affymetrix Recent Development
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Details
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
11.8.5 Fluxion Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Circulating Tumor Cells (CTCs)
Table 4. Key Players of Circulating Tumor DNA (ctDNA)
Table 5. Key Players of Cell-Free DNA (cfDNA)
Table 6. Key Players of Extracellular Vesicles (EVs)
Table 7. Key Players of Others
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2015-2020)
Table 12. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2021-2026)
Table 14. Circulating Biomarker for Liquid Biopsy Market Market Trends
Table 15. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 16. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 17. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 18. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2015-2020)
Table 20. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2019)
Table 21. Global Circulating Biomarker for Liquid Biopsy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Type (2015-2020)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2021-2026)
Table 28. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Application (2015-2020)
Table 29. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Application (2021-2026)
Table 31. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 33. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2015-2020)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 39. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 41. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2015-2020)
Table 43. China Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 44. China Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 45. China Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 46. China Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 47. China Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million) (2015-2020)
Table 48. China Circulating Biomarker for Liquid Biopsy Market Share by Region (2015-2020)
Table 49. Japan Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 51. Japan Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 53. Japan Circulating Biomarker for Liquid Biopsy Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Circulating Biomarker for Liquid Biopsy Market Share by Country (2015-2020)
Table 55. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 57. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 59. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Share by Country (2015-2020)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Product
Table 64. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Becton, Dickinson and Company Company Details
Table 67. Becton, Dickinson and Company Business Overview
Table 68. Becton, Dickinson and Company Product
Table 69. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 70. Becton, Dickinson and Company Recent Development
Table 71. GE Healthcare Company Details
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Product
Table 74. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Epigenomics AG Company Details
Table 77. Epigenomics AG Business Overview
Table 78. Epigenomics AG Product
Table 79. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 80. Epigenomics AG Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Product
Table 84. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Biocept Company Details
Table 87. Biocept Business Overview
Table 88. Biocept Product
Table 89. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 90. Biocept Recent Development
Table 91. Affymetrix Company Details
Table 92. Affymetrix Business Overview
Table 93. Affymetrix Product
Table 94. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 95. Affymetrix Recent Development
Table 96. Fluxion Biosciences Business Overview
Table 97. Fluxion Biosciences Product
Table 98. Fluxion Biosciences Company Details
Table 99. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (US$ Million)
Table 100. Fluxion Biosciences Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2020 VS 2026
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Circulating Tumor DNA (ctDNA) Features
Figure 4. Cell-Free DNA (cfDNA) Features
Figure 5. Extracellular Vesicles (EVs) Features
Figure 6. Others Features
Figure 7. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2026
Figure 8. Early Cancer Screening Case Studies
Figure 9. Therapy Selection Case Studies
Figure 10. Treatment Monitoring Case Studies
Figure 11. Recurrence Monitoring Orthopedics Case Studies
Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions: 2020 VS 2026
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2021-2026)
Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2019
Figure 17. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2019
Figure 19. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 47. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 48. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 49. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 50. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 51. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 52. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 53. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed